Solasia Pharma K.K. (4597.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.6x

Market Cap

JPY 6.89B

MomentumView details →

1D Return

+0.00%

YTD Return

+0.00%

RSI (14)

45.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.6x

Market Cap

JPY 6.89B

RSI (14)

45.9

MomentumView details →

1D Return

+0.00%

YTD Return

+0.00%

ProfitabilityView details →

Gross Margin

48.25%

Net Margin

−204.20%

EBITDA Margin

—

ROE (TTM)

−50.00%

ROA (TTM)

−40.84%

Asset Turnover

0.19x

GrowthView details →

Revenue YoY

+35.76%

EPS YoY

+61.49%

FCF YoY

—

Revenue CAGR 3Y

−26.76%

EPS CAGR 3Y

+62.23%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

6.06x

Quick Ratio

5.70x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

410.00M

Net Income (TTM)

−891.00M

Op. CF (TTM)

−1.12B

Next earningsNov 16, 2026 →

Latest newsMore news →

No recent news for 4597.T.

Similar companies

CellSource Co.,Ltd.4880.T Nano Holdings,Inc.4571.T PRISM BioLab Co.,LTD206A.T Noile-Immune Biotech Inc.4893.T J-Pharma Co.,Ltd.520A.T Tsubota Laboratory Incorporated4890.T Find similar companies →

Latest newsMore news →

No recent news for 4597.T.